Cohance Lifesciences Limited has informed the Exchange about Schedule of meet
COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has disclosed its schedule of upcoming meetings with analysts and institutional investors as per SEBI LODR regulations. The company will participate in three investor conferences: 360 ONE Capital's 16th Annual Investor Conference (May 29, 2026 in Mumbai), BofA Healthcare Tour (June 4, 2026 in Hyderabad), and Goldman Sachs CRO/CDMO Tour (June 11, 2026). The 360 ONE Capital meeting was rescheduled from May 27 to May 29, 2026. The company clarified that no unpublished price-sensitive information (UPSI) will be shared during these interactions.
This is a routine investor relations disclosure with no immediate impact on the stock. The company's participation in multiple major investor conferences indicates active IR engagement. The rescheduling notice and UPSI disclaimer are standard compliance safeguards.